Sir Philip Hampton
Sir Philip Hampton - download image (JPG)
Sir Philip was appointed to the GlaxoSmithKline plc Board on 1 January 2015. He was appointed as Deputy Chairman from 1 April 2015 and as Chairman from 7 May 2015.
Prior to joining GSK, Sir Philip chaired major FTSE 100 companies, including The Royal Bank of Scotland Group plc and J Sainsbury plc. He has also served as Group Finance Director at Lloyds TSB Group, BT Group plc, BG Group plc, British Gas plc and British Steel plc. Sir Philip was previously appointed an Executive Director of Lazards and a Non-Executive Director at RMC Group Plc and Belgacom SA. Until 2009, he was Chairman of UK Financial Investments Limited, which manages the UK Government’s shareholdings in banks. Sir Philip was the Senior Independent Director of Anglo American Plc between 2014 and 2018, having served on its Board since 2009.
Sir Philip is Chair of the Hampton-Alexander Review of FTSE Women Leaders, an independent review on improving gender balance in FTSE leadership.
As announced in January 2019, Sir Philip will step down as Non-Executive Chairman and the Board has started the process of identifying his successor.
Find out more
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Discover our latest financial performance announcement and search for historical quarterly results materials
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business